These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31348085)

  • 1. Dynamic FET PET Imaging of a "Butterfly" IDH-Wildtype Anaplastic Astrocytoma.
    Galldiks N; Brunn A; Fink GR; Langen KJ
    Clin Nucl Med; 2019 Oct; 44(10):e581-e582. PubMed ID: 31348085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Static and dynamic
    Verger A; Stoffels G; Bauer EK; Lohmann P; Blau T; Fink GR; Neumaier B; Shah NJ; Langen KJ; Galldiks N
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):443-451. PubMed ID: 29043400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[
    Bauer EK; Stoffels G; Blau T; Reifenberger G; Felsberg J; Werner JM; Lohmann P; Rosen J; Ceccon G; Tscherpel C; Rapp M; Sabel M; Filss CP; Shah NJ; Neumaier B; Fink GR; Langen KJ; Galldiks N
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1486-1495. PubMed ID: 32034446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic
    Vettermann F; Suchorska B; Unterrainer M; Nelwan D; Forbrig R; Ruf V; Wenter V; Kreth FW; Herms J; Bartenstein P; Tonn JC; Albert NL
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2581-2589. PubMed ID: 31410540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence-guidance in non-Gadolinium enhancing, but FET-PET positive gliomas.
    Schebesch KM; Brawanski A; Doenitz C; Rosengarth K; Proescholdt M; Riemenschneider MJ; Grosse J; Hellwig D; Höhne J
    Clin Neurol Neurosurg; 2018 Sep; 172():177-182. PubMed ID: 30032095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasively detecting Isocitrate dehydrogenase 1 gene status in astrocytoma by dynamic susceptibility contrast MRI.
    Tan W; Xiong J; Huang W; Wu J; Zhan S; Geng D
    J Magn Reson Imaging; 2017 Feb; 45(2):492-499. PubMed ID: 27367599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Dynamic O-(2-[
    Lohmann P; Piroth MD; Sellhaus B; Weis J; Geisler S; Oros-Peusquens AM; Mohlberg H; Amunts K; Shah NJ; Galldiks N; Langen KJ
    World Neurosurg; 2018 Nov; 119():e653-e660. PubMed ID: 30077752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [
    Henriksen OM; Hansen AE; Muhic A; Marner L; Madsen K; Møller S; Hasselbalch B; Lundemann MJ; Scheie D; Skjøth-Rasmussen J; Poulsen HS; Larsen VA; Larsson HBW; Law I
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4677-4691. PubMed ID: 35907033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting IDH genotype in gliomas using FET PET radiomics.
    Lohmann P; Lerche C; Bauer EK; Steger J; Stoffels G; Blau T; Dunkl V; Kocher M; Viswanathan S; Filss CP; Stegmayr C; Ruge MI; Neumaier B; Shah NJ; Fink GR; Langen KJ; Galldiks N
    Sci Rep; 2018 Sep; 8(1):13328. PubMed ID: 30190592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma.
    Auer TA; Kern M; Fehrenbach U; Tanyldizi Y; Misch M; Wiener E
    Neuroradiol J; 2021 Oct; 34(5):392-400. PubMed ID: 33573473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.
    Shirahata M; Ono T; Stichel D; Schrimpf D; Reuss DE; Sahm F; Koelsche C; Wefers A; Reinhardt A; Huang K; Sievers P; Shimizu H; Nanjo H; Kobayashi Y; Miyake Y; Suzuki T; Adachi JI; Mishima K; Sasaki A; Nishikawa R; Bewerunge-Hudler M; Ryzhova M; Absalyamova O; Golanov A; Sinn P; Platten M; Jungk C; Winkler F; Wick A; Hänggi D; Unterberg A; Pfister SM; Jones DTW; van den Bent M; Hegi M; French P; Baumert BG; Stupp R; Gorlia T; Weller M; Capper D; Korshunov A; Herold-Mende C; Wick W; Louis DN; von Deimling A
    Acta Neuropathol; 2018 Jul; 136(1):153-166. PubMed ID: 29687258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological tumour volumes of gliomas in early and standard 20-40 min
    Unterrainer M; Winkelmann I; Suchorska B; Giese A; Wenter V; Kreth FW; Herms J; Bartenstein P; Tonn JC; Albert NL
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1242-1249. PubMed ID: 29487977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors.
    Jaber M; Wölfer J; Ewelt C; Holling M; Hasselblatt M; Niederstadt T; Zoubi T; Weckesser M; Stummer W
    Neurosurgery; 2016 Mar; 78(3):401-11; discussion 411. PubMed ID: 26366972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status.
    Hyare H; Rice L; Thust S; Nachev P; Jha A; Milic M; Brandner S; Rees J
    Eur J Radiol; 2019 May; 114():120-127. PubMed ID: 31005161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaplastic astrocytoma.
    Grimm SA; Chamberlain MC
    CNS Oncol; 2016 Jul; 5(3):145-57. PubMed ID: 27230974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
    Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
    J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Static FET-PET and MR Imaging in Anaplastic Gliomas (WHO III).
    Bette S; Peschke P; Kaesmacher J; Delbridge C; Pyka T; Schmidt-Graf F; Zimmer C; Meyer B; Ringel F; Gempt J
    World Neurosurg; 2016 Jul; 91():524-531.e1. PubMed ID: 26947726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET.
    Vettermann FJ; Felsberg J; Reifenberger G; Hasselblatt M; Forbrig R; Berding G; la Fougère C; Galldiks N; Schittenhelm J; Weis J; Albert NL; Schüller U
    Clin Nucl Med; 2018 Dec; 43(12):895-898. PubMed ID: 30358620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare case of a molecular "adult-type" diffuse astrocytoma arising in a child.
    Pegolo E; Tosolini R; Nardini N; Passone E; Cogo P
    Childs Nerv Syst; 2018 Feb; 34(2):191-193. PubMed ID: 29198071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.